Abiopharma

Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision

Morris Steven B 🟢 acquired 1.2K shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) Transaction Date: Dec 17, 2025 | Filing ID: 000031

Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision

Plautz David J. 🟢 acquired 1.0K shares (1 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) Transaction Date: Dec 17, 2025 | Filing ID: 000030

Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth

Tornehl Tobin 🟢 acquired 1.7K shares (4 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) Transaction Date: Dec 17, 2025 | Filing ID: 000029

Vanderleest Adam 🟢 acquired 410 shares (3 derivative) of SENSIENT TECHNOLOGIES CORP (SXT) Transaction Date: Dec 17, 2025 | Filing ID: 000028

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

New Form SCHEDULE 13G - Trulieve Cannabis Corp. Filed: 2025-12-18 AccNo: 0002048490-25-000010 Size: 7 KB

Trinity Biotech plc (TRIB) Files Form 6-K

New Form 8-K/A - ProPhase Labs, Inc. Filed: 2025-12-18 AccNo: 0001493152-25-028317 Size: 5 MB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq